Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
|
|
Ikena Oncology, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 105,000 options to buy
@ $2.62, valued at
$275.1k
|
|
| 01/05/2023 |
4
| Ecsedy Jeffrey (Chief Development Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 105,000 options to buy
@ $2.62, valued at
$275.1k
|
|
| 01/05/2023 |
4
| Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 105,000 options to buy
@ $2.62, valued at
$275.1k
|
|
| 01/05/2023 |
4
| Manfredi Mark (President & CEO) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 220,000 options to buy
@ $2.62, valued at
$576.4k
|
|
| 01/05/2023 |
4
| Marango Jotin (CFO & Head of Corp. Dev.) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 105,000 options to buy
@ $2.62, valued at
$275.1k
|
|
| 12/19/2022 |
4
| Hughes Owen (Director) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 35,040 options to buy
@ $2.62, valued at
$91.8k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2022 |
4
| Marango Jotin (CFO & Head of Corp. Dev.) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 397,199 options to buy
@ $5.88, valued at
$2.3M
|
|
| 02/04/2022 |
4
| Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 40,000 options to buy
@ $11.45, valued at
$458k
|
|
| 02/04/2022 |
4
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 70,400 options to buy
@ $11.45, valued at
$806.1k
|
|
| 02/04/2022 |
4
| Manfredi Mark (President & CEO) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 238,900 options to buy
@ $9.76, valued at
$2.3M
|
|
| 02/04/2022 |
4
| Ecsedy Jeffrey (Chief Development Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 59,360 options to buy
@ $11.45, valued at
$679.7k
|
|
| 02/04/2022 |
4
| Tessier Maude (Chief Business Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 40,000 options to buy
@ $11.45, valued at
$458k
|
|
| 01/25/2022 |
4
| Wooster Richard (Director) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 29,200 options to buy
@ $11.06, valued at
$323k
|
|
| 01/20/2022 |
4
| Tessier Maude (Chief Business Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Exercised 38,915 options to buy
@ $2.94, valued at
$114.4k
Exercised 24,606 options to buy
@ $4.15, valued at
$102.1k
Exercised 8,265 options to buy
@ $4.51, valued at
$37.3k
|
|
| 01/12/2022 |
4
| Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Sold 36 shares
@ $12, valued at
$432
Sold 964 shares
@ $12, valued at
$11.6k
Exercised 36 options to buy
@ $2.1462, valued at
$77.3
Exercised 964 options to buy
@ $2.1462, valued at
$2.1k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 176,699 options to buy
@ $13.75, valued at
$2.4M
|
|
|
|
|